We found that topical ozone treatment significantly decreased the IMQ-induced expression levels of TLR2, P50, and P65 in the mouse model (Figure 4a and b) and in patients with psoriasis (Figure 4c). The gene discussed is NFKB1; the disease is psoriasis.